Eleanor Garth

Federal court ruling highlights growing pressure for quality assurance as longevity interventions move into increasingly crowded market.

London event expands as founders, investors and clinicians gather alongside researchers to explore the future of preventive health.

Six of seven compounds clear a reconstituted committee, as questions mount over evidence, access and who benefits.

New international consortium argues healthy aging's foundations are laid long before old age – perhaps before birth itself.

A bootstrapped company is betting that precision formulation, sourcing and everyday habits matter as much as the next fashionable molecule.

Vivoo's CEO explains how continuous biomarker monitoring and passive diagnostics could shift healthcare from episodic treatment to prevention.

Ahead of Longevity Investors Conference, Steve Horvath discusses how to separate genuine aging science from persuasive biological storytelling

Integrated longevity platform aims to make continuous preventive healthcare more accessible as it prepares for international expansion.

A new evolutionary framework suggests research into female biology could reveal overlooked clues to healthier aging.

A single AAV injection protected five organs in aged mice – and raises pointed questions for geroscience, not least how fast it might travel.